AI & FDA Compliance

Artificial Intelligence (AI) in FDA-Regulated Systems:

AI is not inherently noncompliant.
The real risk is using unverified AI output to support regulated decisions without appropriate review and governance.

  • AI copilots
  • AI-assisted drafting
  • embedded AI features
  • AI-supported decision tools
  • defined review expectations
  • AI governance procedures
  • risk-based verification approaches
  • procedural consistency

Traditional software validation is based on predictable, deterministic behavior where the same input consistently produces the same output.

As a result, organizations cannot rely on blind acceptance of AI-generated output.

Instead, review rigor, verification, procedural governance, and human accountability become critical controls for ensuring regulated decisions remain accurate, defensible, and appropriately governed.


Understanding the context of AI use is essential. The closer AI gets to regulated decisions, controlled records, or validated systems, the greater the expectation for governance and procedural control.


Most QMS procedures were written before:

  • AI copilots
  • embedded AI suggestions
  • AI-assisted decision support

Organizations may need to define:

  • acceptable AI use
  • review expectations
  • verification requirements
  • documentation expectations
  • approval responsibilities